W. Lowry Caudill

W. Lowry Caudill is a Series A investor at Southern Capitol Ventures in Durham focused on Biopharma and Therapeutics. Lowry Caudill is the retired, worldwide President of Pharmaceutical Development for Cardinal Health. The Pharmaceutical Development business unit provided complete development services for the pharmaceutical industry. Caudill led over 1400 employees in nine sites including RTP, San Diego, Somerset NJ, Philadelphia, Manchester UK and Schorndorf GER.In April 2002, Cardinal Health acquired Magellan Laboratories Incorporated, a pharmaceutical development company that Caudill and Alfred Childers co-founded in 1991. Under their leadership Magellan grew to 600 people with 500 employees in RTP and 100 employees in San Diego. Magellan was recognized as one of the fastest growing, privately held companies in the Research Triangle area and received numerous regional and national awards for growth and entrepreneurial development. Magellan was awarded the Triangle Business Journal’s Fast 50 award for nine years and was in the Top 10 for six of the nine years. In 1998, Drs. Caudill and Childers were named Entrepreneur of the Year for North and South Carolina by Ernst and Young, the Kauffman Foundation, USA TODAY, and NASDAQ and were Finalists for the 1998 National Entrepreneur Of The Year. They received two awards from the North Carolina Council for Entrepreneurial Development (CED), the 2002 Entrepreneurial Excellence Award and the 2002 Deal of the Year Award.Caudill received his B.S. degree in Chemistry at the University of North Carolina at Chapel Hill with undergraduate research under the direction of Professor Royce Murray. In 1983, Caudill received his doctorate in Analytical Chemistry from Indiana University under the direction of Professor R. Mark Wightman. His dissertation was titled Development and Application of High Performance Liquid Chromatography with Electrochemical Detection. Upon graduation, he became a research scientist at Baxter-Travenol. In addition to general fanatical activities, he managed a formulation development laboratory, which was responsible for the formulation, development and stability evaluation of frozen premixed parenteral products. In 1987, he joined the Glaxo Research Institute where he played a major role in the establishment of the Analytical Chemistry Department in RTP. Currently marketed product lines which his groups helped develop include Zantac, Imitrex, Zofran, Zinacef, and Ventolin.Caudill is an active entrepreneur and supporter of entrepreneurial endeavors. He serves on the Advisory Board of Southern Capitol Ventures, serves on the Life Sciences Advisory Board of the Aurora Funds and is a member of the Tri-State Investment Group. He is an investor in and member of the Board of Directors of Liquidia Technologies Incorporated. He is a former board member of and investor in Knowledge Vector, Piedmont Pharmaceuticals and Aldagen Inc.Caudill is Chair of the Board of Trustees at the University of North Carolina at Chapel Hill and of the University’s Innovation Circle. He was a Steering Committee member of the $2.4 billion Carolina First Campaign and is chair of the Private Fundraising Steering Committee for the UNC-CH Physical Science Complex. He is an Adjunct Professor of Chemistry at the UNC-CH and a member of the UNC-CH Chemistry Department External Advisory Board. He is a member of the Advisory Working Group for the UNC-CH Entrepreneurship Minor and is chair of the Private Fundraising Campaign for the Entrepreneurship Minor. He and Professor Holden Thorp created and taught the first Scientific Ventures course for the UNC-CH Entrepreneurship Minor. In the spring semesters of 2008 and 2009, he co-taught the Scientific Ventures course with Professor Joe DeSimone. He co-taught the Introduction to Entrepreneurship course in 2007 and 2008 for the Entrepreneurship Minor. He is a member of the Executive Board of The Educational Foundation at UNC-CH. In 2008, he received the Distinguished Alumnus Award from UNC-CH.He is an active member of the American Chemical Society (ACS) and the American Association of Pharmaceutical Scientists (AAPS).Dr. Caudill has chaired numerous boards at Aldersgate United Methodist Church in Durham, NC and presently serves as chair of the Administrative Board and the Building Committee. He was a Team Leader for the Aldersgate 2008 Jamaica Mission Team. Dr. Caudill, and his wife, Suzi, and children reside in Durham. His oldest daughter is a senior at UNC-CH and his son is a sophomore at UNC-CH.